Verywell Health on MSN10h
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
Medindia20h
FDA Approves Esketamine Nasal Spray for Resistant Depression
FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...
What's Going On With NRX Pharmaceuticals Stock Tuesday?
NRX Pharmaceuticals shares are moving higher on Tuesday after it invested $27 million in its subsidiary HOPE Therapeutics.
NRx Pharmaceuticals invests $27M in subsidiary Hope for clinic acquisitions
NRx Pharmaceuticals (NRXP)’ wholly-owned subsidiary Hope Therapeutics signed a Stock Purchase Agreement with Smith & Sauer as the first ...
freedommag17h
New Research Finds Dangerous Psychedelic Drugs Misrepresented by Psychiatry
With profit as the most obvious motive, psychiatry is pushing dangerous psychedelic drugs at every turn. New research studies ...